NDC 0409-7447-16 - Cimetidine in Sodium Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-7447
- Requested NDC
- 0409-7447-16
- Package NDCs from labels
- 0409-7447-16
- Manufacturer
- HOSPIRA, INC.
- Effective date
- 2006-04-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CIMETIDINE in 0.9% Sodium Chloride Injection, USP | HOSPIRA, INC. | 2006-04-13 | Human prescription drug label |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Cimetidine | ACTIVE INGREDIENT | 80061L1WGD | CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Cimetidine | ACTIVE MOIETY | 80061L1WGD | CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dobutamine in Dextrose | DOBUTAMINE IN DEXTROSE | Hospira, Inc. | 9943a961-3b50-4847-8a84-d8414ce38daa | 2026-11-06 | Warnings, Adverse reactions | Hospira, Inc. |
| Metronidazole | METRONIDAZOLE | Hospira, Inc. | 49360d6f-c8b3-420e-af75-154cf7b05255 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Methotrexate | METHOTREXATE | Hospira, Inc. | bd287e89-32f9-4396-95fa-4b562869f476 | 2026-10-29 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Methotrexate | METHOTREXATE | Hospira, Inc. | 0e30eaef-5a09-4104-8a11-c32933eadeab | 2026-10-29 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | Cardinal Health 107, LLC | 97007188-43fe-416c-a87b-6ccc4d9ae2ec | 2026-10-28 | Adverse reactions | Sodium Chloride |
| Methotrexate | METHOTREXATE | Hospira, Inc. | 0d63ba29-b692-41b4-87e8-351265c8273f | 2026-10-27 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Marcaine | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | 67578b56-7540-487e-1fba-481255620e78 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Dopamine Hydrochloride in Dextrose | DOPAMINE HYDROCHLORIDE IN DEXTROSE | Hospira, Inc. | 08f23f6e-150d-45ea-098e-f2edf64c21a1 | 2026-10-21 | Warnings, Adverse reactions | Hospira, Inc. |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | 89a4bd73-89f4-4fd7-2c9f-921e1da8f96b | 2026-10-20 | Warnings, Adverse reactions | Hospira, Inc. |
| Cytarabine | CYTARABINE | Hospira, Inc. | e3a8c0e9-19ed-49b7-8464-11e8806f47fd | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Nipent | PENTOSTATIN | Hospira, Inc. | 674e0e6d-46ed-4868-9196-04019d667716 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | 3b2dd84e-cee8-4e58-d494-395a65a353a0 | 2026-10-19 | Warnings, Adverse reactions | Hospira, Inc. |
| Morphine Sulfate | MORPHINE SULFATE | Hospira, Inc. | be420e8b-bcb0-49b5-bb4d-1df8b9959809 | 2026-10-14 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Cisatracurium Besylate | CISATRACURIUM BESYLATE | Hospira, Inc. | 67908e20-044d-454d-9c51-bf106e817bd0 | 2026-10-14 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | CODAN US CORPORATION | aa06e286-75c6-4d7a-959f-6008d38aa6e5 | 2026-10-08 | Warnings, Adverse reactions | Sodium Chloride |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2026-10-08 | Warnings, Adverse reactions | Sodium Chloride |
| Sodium Chloride | SODIUM CHLORIDE | SOLA Pharmaceuticals, LLC | 4d0bfd28-460a-48ba-bd17-cf75e56d62f4 | 2026-10-08 | Warnings, Adverse reactions | Sodium Chloride |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-10-08 | Warnings, Adverse reactions | Sodium Chloride |
| Butorphanol Tartrate | BUTORPHANOL TARTRATE | Hospira, Inc. | 9822ca3f-aee2-46e5-8a96-495400e65d10 | 2026-10-06 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Cytarabine | CYTARABINE | Hospira, Inc. | 277597b0-7d85-40a3-a34a-70c6a883fc6d | 2026-09-30 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.